Cover Image

Synthesis and biological evaluation of 2-styrylquinolines as antitumour agents and EGFR kinase inhibitors: molecular docking study

A new series of 4,6-disubstituted 2-(4-(dimethylamino)styryl)quinoline 4a,b-9a,b was synthesized by the reaction of 2-(4-(dimethylamino)styryl)-6-substituted quinoline-4-carboxylic acids 3a,b with thiosemicarbazide, p-hydroxybenzaldehyde, ethylcyanoacetate, and 2,4-pentandione. In addition, the anti...

Full description

Saved in:

Bibliographic Details
Main Authors:	Magda A.- (Author), Walaa M. El-Husseiny (Author), Naglaa I. Abdel-Aziz (Author), Adel S. El-Azab (Author), Hatem A. Abuelizz (Author), Alaa A.-M (Author)
Format:	Book
Published:	Taylor & Francis Group, 2018-01-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Synthesis, antitumour and antioxidant activities of novel α,β-unsaturated ketones and related heterocyclic analogues: EGFR inhibition and molecular modelling study
by: Walaa M. El-Husseiny, et al.
Published: (2018)

Synthesis, antitumour activities and molecular docking of thiocarboxylic acid ester-based NSAID scaffolds: COX-2 inhibition and mechanistic studies
by: Adel S. El-Azab, et al.
Published: (2018)

Synthesis, in vitro antitumour activity, and molecular docking study of novel 2-substituted mercapto-3-(3,4,5-trimethoxybenzyl)-4(3H)-quinazolinone analogues
by: Adel S. El-Azab, et al.
Published: (2017)

Synthesis, antitumor activity, and molecular docking study of 2-cyclopentyloxyanisole derivatives: mechanistic study of enzyme inhibition
by: Walaa M. El-Husseiny, et al.
Published: (2020)

Novel alloxazine analogues: design, synthesis, and antitumour efficacy enhanced by kinase screening, molecular docking, and ADME studies
by: Doaa Samaha, et al.
Published: (2024)

Synthesis, anticancer and apoptosis-inducing activities of quinazoline-isatin conjugates: epidermal growth factor receptor-tyrosine kinase assay and molecular docking studies
by: Adel S. El-Azab, et al.
Published: (2017)

Synthesis of novel spirochromane incorporating Schiff's bases, potential antiproliferative activity, and dual EGFR/HER2 inhibition: Cell cycle analysis and in silico study
by: Dina I.A. Othman, et al.
Published: (2023)

Synthesis, anticancer, apoptosis-inducing activities and EGFR and VEGFR2 assay mechanistic studies of 5,5-diphenylimidazolidine-2,4-dione derivatives: Molecular docking studies
by: Hamad M. Alkahtani, et al.
Published: (2019)

Design, synthesis, and analysis of antiproliferative and apoptosis-inducing activities of nitrile derivatives containing a benzofuran scaffold: EGFR inhibition assay and molecular modelling study
by: Salma Fares, et al.
Published: (2021)

Development of certain benzylidene coumarin derivatives as anti-prostate cancer agents targeting EGFR and PI3Kβ kinases
by: Lina M. A. Abdel Ghany, et al.
Published: (2024)

Design, synthesis, and carbonic anhydrase inhibition activities of Schiff bases incorporating benzenesulfonamide scaffold: Molecular docking application
by: Adel S. El-Azab, et al.
Published: (2023)

Click chemistry based synthesis, cytotoxic activity and molecular docking of novel triazole-thienopyrimidine hybrid glycosides targeting EGFR
by: Reham R. Khattab, et al.
Published: (2021)

Novel 2-(5-Aryl-4,5-Dihydropyrazol-1-yl)thiazol-4-One as EGFR Inhibitors: Synthesis, Biological Assessment and Molecular Docking Insights
by: Al-Warhi T, et al.
Published: (2022)

Synthesis, potential antitumor activity, cell cycle analysis, and multitarget mechanisms of novel hydrazones incorporating a 4-methylsulfonylbenzene scaffold: a molecular docking study
by: Alaa A.-M, et al.
Published: (2021)

Design, synthesis and antitumour activity evaluation of novel dolutegravir derivatives
by: Xi-Xi Hou, et al.
Published: (2023)

Recent advances in 4-aminoquinazoline based scaffold derivatives targeting EGFR kinases as anticancer agents
by: Rania S.M. Ismail, et al.
Published: (2016)

Synthesis, anti-inflammatory, cytotoxic, and COX-1/2 inhibitory activities of cyclic imides bearing 3-benzenesulfonamide, oxime, and β-phenylalanine scaffolds: a molecular docking study
by: Alaa A.-M, et al.
Published: (2020)

Synthesis, docking study, and structure-activity relationship of novel niflumic acid derivatives acting as anticancer agents by inhibiting VEGFR or EGFR tyrosine kinase activities
by: Yahya Yaseen, et al.
Published: (2022)

Design, synthesis, and antitumor efficacy of novel 5-deazaflavin derivatives backed by kinase screening, docking, and ADME studies
by: Walaa A. Bedewy, et al.
Published: (2023)

R(h)oad to antitumour therapy
by: Viviane Nascimento Da Conceicao, et al.
Published: (2022)

In vivo antitumour potential of camel's milk against hepatocellular carcinoma in rats and its improvement of cisplatin renal side effects
by: Hala M. F. El Miniawy, et al.
Published: (2017)

Triazoloquinoxalines-based DNA intercalators-Topo II inhibitors: design, synthesis, docking, ADMET and anti-proliferative evaluations
by: Alaa Elwan, et al.
Published: (2022)

The Antitumour Mechanisms of Carotenoids: A Comprehensive Review
by: Andrés Baeza-Morales, et al.
Published: (2024)

Mechanisms of resistance to EGFR tyrosine kinase inhibitors
by: Lihua Huang, et al.
Published: (2015)

Design, synthesis, docking, MD simulations, and anti-proliferative evaluation of thieno[2,3-d]pyrimidine derivatives as new EGFR inhibitors
by: Eman A. Sobh, et al.
Published: (2023)

Fabrication of Anti-HSV-1 Curcumin Stabilized Nanostructured Proniosomal Gel: Molecular Docking Studies on Thymidine Kinase Proteins
by: Shady M. Abd El-Halim, et al.
Published: (2020)

Synthesis, biological evaluation and in silico molecular docking of novel 1-hydroxy-naphthyl substituted heterocycles
by: El-Sayed, et al.
Published: (2018)

Saikosaponin D: review on the antitumour effects, toxicity and pharmacokinetics
by: Piao Zhou, et al.
Published: (2021)

Benzo[g]quinazolines as antifungal against candidiasis: Screening, molecular docking, and QSAR investigations
by: Hatem A. Abuelizz, et al.
Published: (2023)

2-Arylquinolines as novel anticancer agents with dual EGFR/FAK kinase inhibitory activity: synthesis, biological evaluation, and molecular modelling insights
by: Mostafa M. Elbadawi, et al.
Published: (2022)

Impact of MET alterations on targeted therapy with EGFR-tyrosine kinase inhibitors for EGFR-mutant lung cancer
by: Zhe Zhang, et al.
Published: (2019)

Primary Resistance to EGFR Tyrosine Kinase Inhibitors (TKIs): Contexts and Comparisons in EGFR-Mutated Lung Cancer
by: Keigo Kobayashi
Published: (2023)

4-Aryl-N-phenylpyrimidin-2-amines targeting EGFR-tyrosine kinase attenuated EGFR-expressing cell lines
by: Lueacha Tabtimmai, et al.
Published: (2022)

Antipruritic vs. Antitumour Action of Aprepitant: A Question of Dose
by: Miguel Muñoz, et al.
Published: (2019)

Progress in Understanding the Molecular Mechanisms Underlying the Antitumour Effects of Ivermectin
by: Liu J, et al.
Published: (2020)

Interactions between rnacrophage cytokines and eicosanoids in expression of antitumour activity
by: Shlomo Ben-Efraim
Published: (1992)

Computational insights into the stereo-selectivity of catechins for the inhibition of the cancer therapeutic target EGFR kinase
by: Mohd Rehan, et al.
Published: (2024)

Editorial: Discovery of EGFR tyrosine kinase inhibitors for cancer treatment
by: Panupong Mahalapbutr, et al.
Published: (2024)

Synthesis and anticancer activity of new quinazoline derivatives
by: Hatem A. Abuelizz, et al.
Published: (2017)

Design, synthesis, antitumor evaluation, and molecular docking of novel pyrrolo[2,3-d]pyrimidine as multi-kinase inhibitors
by: Ashwag S. Alanazi, et al.
Published: (2023)